News Release

April 17,2019
The PⅠ/Ⅱa clinical trial of FPP003(Antibody-inducing peptide) starts in Australia.
February 26,2019
FunPep is approved the PⅠ/Ⅱa clinical trial plan of FPP003 (antibody-inducing peptide) by HREC in Australia.
February 18,2019
FunPep contracts the joint research agreement with Shionogi for antibody-inducing peptide on pain territory.
October 5,2018
Announcement of fund raising through third-party allotment of new shares
September 20,2018
To develop antibody-inducing peptides for ankylopoietic spondylarthritis, industry-academia collaboration project selected by AMED
August 29,2018
Published the FunPep article on the Nikkei newspapers
August 10,2018
FunPep starts an AI research to develop efficiently Antibody-Inducing Peptides with Future Corp. and Osaka Univ.
June 5,2018
Re. functional peptide SR-0379, the P2 clinical trial notification submitted by Shionogi.
April 9,2018
FunPep enters into an option agreement on antibody inducing peptides with Sumitomo Dainippon Pharma.
March 20,2018
The new mild cleansing shampoo with a joint development between Fancl and FunPep released on March 20, 2018.
May 15,2017
FunPep signs the joint research agreement to develop anti-virus drug with Fujifilm.
January 18,2017
FunPep wins the MEXT Minister’s Award of the 10th Japan Bio Venture Award 2017.
December 14,2016
FunPep announces to enter into the collaboration research agreement on adjuvant with Shinogi.
October 3,2016
FunPep announces to be rewarded with grant from the Active Osaka Promotion Fund.
September 16,2016
FunPep announces to enter into the collaboration research agreement on Antibody-inducing peptides with Sumitomo Dainippon Pharma.